Development and validation of a leukocyte‐associated immunoglobulin‐like receptor‐1 prognostic signature for lower‐grade gliomas
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4945
Abstract: Leukocyte‐associated immunoglobulin‐like receptor‐1 (LAIR‐1), is an immunosuppressive receptor, widely expressed by immune cells, but the part of LAIR‐1 in glioma progression remains unclear. The purpose of this study was to explore the relationship between LAIR‐1… read more here.
Keywords: like receptor; associated immunoglobulin; leukocyte associated; receptor ... See more keywords
Increased concentration of soluble leukocyte-associated immunoglobulin-like receptor (LAIR) in sera from patients with blistering diseases: possible pathophysiological implications?
Sign Up to like & getrecommendations! Published in 2022 at "Minerva medica"
DOI: 10.23736/s0026-4806.22.07652-2
Abstract: BACKGROUND Autoimmune Blistering Diseases (AIBD), are a heterogeneous group. Despite their pathogenesis is not completely understood, autoantibodies against directed adhesion molecules of the skin and adjacent mucous membranes could play a key role. The leukocyte-associated-Ig-like-receptor… read more here.
Keywords: lair; blistering diseases; receptor lair; like receptor ... See more keywords